NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-145-2009-0-US-01 Pyro-glutamate Serpinin (pE-Serpinin), A Novel Protection Peptide Against Oxidative Stress In Cell And A Biomarker For Inflammatory Disease US 61/172,013 Abandoned
NHGRI E-053-2009-0-US-01 Methods for Diagnosis and Prognosis of Melanoma by Detection of Somatic Mutations in the MITF Pathway US 61/214,415 Abandoned
NINDS E-081-2008-2-EP-04 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems EP National Stage 09731740.8 Abandoned
NINDS E-081-2008-2-FR-09 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems FR EP 09731740.8 Abandoned
NINDS E-081-2008-2-DE-08 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems DE EP 09731740.8 Abandoned
NINDS E-081-2008-2-GB-10 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems GB EP 09731740.8 Abandoned
NINDS E-081-2008-2-CA-03 Magnetic Microstructures For Magnetic Resonance Imaging CA National Stage 2721797 Abandoned
NINDS E-081-2008-2-AU-02 Magnetic Microstructures For Magnetic Resonance Imaging (MRI) Systems AU National Stage 2009237570 Abandoned
NIAID E-285-2002-0-ES-22 Lutzomyia Longipalpis Polypeptides and Methods of Use ES EP 09158294.0 Expired
NIAID E-285-2002-0-FR-23 Lutzomyia Longipalpis Polypeptides and Methods of Use FR EP 09158294.0 Expired
NIAID E-285-2002-0-IT-24 Lutzomyia Longipalpis Polypeptides and Methods of Use IT EP 09158294.0 Expired
NIAID E-285-2002-0-EP-14 Lutzomyia Longipalpis Polypeptides and Methods of Use EP DIV 09158294.0 Expired
NINDS E-081-2008-2-PCT-01 MAGNETIC MICROSTRUCTURES FOR MAGNETIC RESONANCE IMAGING PCT PCT COMB PCT/US2009/041142 Expired
NCI E-308-2000-0-US-10 Expression Vectors Able To Elicit Improved Immune Response and Methods of Using Same US DIV 12/426,901 Abandoned
NICHD E-133-1990-0-US-05 GOSSYPOL FOR THE TREATMENT OF CANCER US CON 12/426,841 Abandoned
NCI E-042-2009-0-US-01 A Human Cytolytic T Lymphocyte Epilope From The Human Tumor-associated Antigen NGEP (new Gene Expressed In Prostate) US 61/170,900 Abandoned
NINDS E-144-2008-0-PCT-02 MRI Movement Correction PCT PCT PCT/US09/40948 Expired
NCI E-049-2008-0-PCT-02 Cripto-l As A Biomarker for Cardiac Hypoxia PCT PCT PCT/US09/40971 Abandoned
NINDS E-144-2008-0-EP-03 MRI Movement Correction in MRI Using A Camera EP National Stage 09731954.5 Abandoned
NCI E-075-2008-0-PCT-02 Cripto-1 As A Biomarker for Chronic Inflammatory Disease PCT PCT PCT/US09/40980 Abandoned
NCI E-184-2009-0-US-01 Combination Immunotherapy Compositions And Methods US 61/170,530 Abandoned
NIAAA E-061-2010-0-EP-02 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE EP National Stage 09789597.3 Issued
NIAAA E-061-2010-0-IN-05 PROCESS FOR THE PREPARATION OF (3R)-HYDROXYBUTYL (3R) - HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE IN National Stage 2333/MUMNP/2011 Abandoned
NIAAA E-060-2010-0-IN-04 Hydroxybutyrate Ester And Medical Use Thereof IN National Stage 544/MUMNP/2011 Abandoned
NIAAA E-060-2010-0-EP-08 DRINK COMPRISING HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF EP National Stage 09789596.5 Issued
NIAAA E-060-2010-0-JP-09 Hydroxybutyrate Ester And Medical Use Thereof JP National Stage 2011-523833 Issued
NIAAA E-061-2010-0-AU-06 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE AU National Stage 2009344282 Issued
NIAAA E-060-2010-0-CN-05 Hydroxybutyrate Ester And Medical Use Thereof CN National Stage 200980136723.1 Abandoned
NIAAA E-060-2010-0-AU-03 Hydroxybutyrate Ester And Medical Use Thereof AU National Stage 2009283171 Abandoned
NIAAA E-061-2010-0-PCT-01 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE PCT PCT PCT/US2009/040773 Expired
NIAAA E-060-2010-0-PCT-02 Hydroxybutyrate Ester And Medical Use Thereof PCT PCT PCT/US2009/040766 Expired
NICHD E-167-2009-0-US-01 Cholesterol Therapy For Autistic Spectrum Disorder US 61/169,775 Abandoned
NIAAA E-061-2010-0-CA-04 PROCESS FOR THE PREPARATION OF (3R).HYDROXYBUTYL (3R) -HYDROXYBUTYRATE BY ENZYMATIC ENANTIOSELECTIVE REDUCTION EMPLOYING LACTOBACILLUS BREVIS ALCOHOL DEHYDROGENASE CA National Stage 2760410 Abandoned
NCI E-174-2008-0-AU-04 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma AU National Stage 2009236219 Issued
NIA E-051-2008-0-AU-03 Compositions And Methods For Delivering Inhibitory Oligonucleotides AU National Stage 2009236270 Abandoned
NCI E-174-2008-0-EP-06 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA EP National Stage 09731523.8 Issued
NIA E-051-2008-0-PCT-02 CHEMOARP -A SIMPLE AND EFFICIENT TECHNOLOGY FOR DELIVERING SIRNA PCT PCT PCT/US2009/040607 Expired
NCI E-174-2008-0-PCT-02 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA PCT PCT PCT/US2009/040685 Expired
NCI E-174-2008-0-EP-11 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNA EP DIV 9731523.8 Abandoned
NIA E-051-2008-0-EP-05 COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES EP National Stage 09733166.4 Abandoned
NIDA E-250-2009-0-US-01 Monoamine Reuptake Inhibitors US 61/169,586 Abandoned
NCI E-174-2008-0-CA-05 Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma CA National Stage 2721380 Abandoned
NIA E-051-2008-0-CA-04 COMPOSITIONS AND METHODS FOR DELIVERING INHIBITORY OLIGONUCLEOTIDES CA National Stage 2720363 Abandoned
NCI E-175-2008-0-US-02 OVER-EXPRESSION AND MUTATION OF A TYROSINE KINASE RECEPTOR FGFR4 IN TUMORS US ORD 12/423,750 8216783 Abandoned PDF
NHLBI E-138-2008-0-PCT-02 Hypertriglyceridemia From ApoA-I And ApoA-I Mimetic Peptides PCT PCT PCT/US2009/040560 Expired
NICHD E-120-2015-0-US-01 Method For On-demand Contraception US 61/169,149 Abandoned
NICHD E-098-2008-0-US-02 Biomarkers for niemann-pick C disease and related disorders US ORD 12/385,529 8497122 Issued PDF
NIAID E-142-2008-0-PCT-02 Humanized Monoclonal Antibodies Derived From Chimpanezee Fabs Efficient For Neutralization Of Japanese Virus (JEV) In Vitro And Protection Against JEV Infection In Mice PCT PCT PCT/US2009/040227 Expired
NIDDK E-173-2008-0-PCT-02 MDCK Cells With Human Siat7e Gene Inserts Exhibit Capability Of Anchorage-independent Growth PCT PCT PCT/US2009/002252 Expired
NCI E-160-2006-0-DE-05 AZONAFIDE DERIVED TUMOR AND CANCER TARGETING COMPOUNDS DE EP 07842310.0 Issued